HIGHLIGHTS
- who: Sophie St-Cyr and collaborators from the Philadelphia, Philadelphia, PA, United States of America, The Perelman School of Medicine, The University have published the paper: Huntington’s disease phenotypes are improved via mTORC1 modulation by small molecule therapy, in the Journal: PLOS ONE of April/22,/2022
- what: The experiments were performed with at least two different cohorts of animals, and all cohorts showed the same trend. For this study, the authors found no significant interaction of stress and cardiac stress and therefore the authors focused on the changes within the vehicle-treated groups . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.